Description
Cetuximab, a novel molecular-targeted agent,is an inhibitor of EGFR monoclonal humanized antibody interacting with the extracellular binding site of EGFR to block ligand stimulation.
Cat.No
A006
Name
Cetuximab
Chemical Properties
CAS
205923-56-4
Synonyms
CETUXIMAB;Erbitux;Hsdb 7454;Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 gamma1-chain), disulfide with human-mouse monoclonal C225 kappa-chain, dimer;Unii-pqx0D8J21j;EGFR antibody;IMC 225;CetuxiMab(C225);ImmunoglobulinG1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 g...;C225;IMC-C 225;C 225;Cetuximab - Buffer solution
pH value
Corresponds to reference standard： PASS
Non-reduced CE-SDS
98.7%
SEC-HPLC
99.5%
Isoelectric Point
Corresponds to reference standard:PASS
Bacterial Endotoxins Test
＜1 EU/ml
Residual Proteins of Host Cell
Exogenous Residual DNA
＜1 pg/mg
Residual protein A
＜1 ng/mg
Biological Activity
Compared with standard, the range of biological activity is 102%
Osmolality
Corresponds to reference standard: PASS
Peptide mapping
Corresponds to reference standard: PASS
N-terminal sequence
Corresponds to reference standard:PASS
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131Fax: +86-21-61642470Email:
Website:
